Dietmar siemssen - Latest News Update, Information, Photos & Videos on Dietmar siemssen at Lokmat Times

Gerresheimer AG, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, confirms guidance for its financial year 2022 after another quarter of strong and profitable growth. Revenue rose organically by 17.4 per cent in the third quarter, reflecting strong customer demand, leading market positions and the ongoing success of its High Value Solutions. Adjusted EBITDA grew organically by 13.3 per cent."Gerresheimer continues on its profitable growth path across all our divisions, business segments and regions reflecting our strong market positions. While steering successfully through a challenging environment, we are consistently pursuing our growth strategy and are boosting our transformation process to become a solution provider and system integrator", said Dietmar Siemssen, CEO of Gerresheimer AG. "We are on track to deliver on our financial year 2022 guidance, and we are clearly committed to our mid-term targets", he affirmed.Press release:For further information:Ueli UtzingerGroup Senior Director Marketing & CommunicationT +49 211 6181-250This story has been provided by PRNewswire.will not be responsible in any way for the content in this article. (ANI/PRNewswire)( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Dietmar SiemssenFOLLOW

Dietmar siemssen, Latest News

Business :Gerresheimer reports double digit growth in revenue and earnings for the third quarter

Gerresheimer AG, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, confirms guidance for its financial year 2022 after another quarter of strong and profitable growth. Revenue rose orga ...